Table 3.
Effect of TAA, SY, and CS ethanolic extracts intake on some in vivo antioxidant parameters in TAA-induced liver cirrhosis in rats.
| Group | CAT (nmol/min/mL) | SOD (U/mL) | GPx (nmol/min/mL) |
|---|---|---|---|
| Normal | 2757.97 ± 49.6b | 350.84 ± 44.3b | 141.12 ± 6.89b |
| TAA | 2111.42 ± 14.38a | 218.46 ± 7.48a | 81.38 ± 4.30 |
| CS100 | 2666.20 ± 99.9b | 332.8 ± 23.6b | 134.2 ± 4.14b |
| CS300 | 2730.76 ± 40.82b | 326.8 ± 32.8b | 136.0 ± 5.78b |
| CS100 + TAA | 2424.68 ± 39.04b,a | 297.36 ± 16.8b | 104.90 ± 9.37b,a |
| CS300 + TAA | 2561.57 ± 57.6b,a | 319.8 ± 82b | 129.63 ± 6.16b |
| SY + TAA | 2620.77 ± 76.8b | 348.0 ± 35.3b | 130.24 ± 5.12b |
The data were stated as mean ± S.E.M. Means with different superscripts are significantly different. a P < 0.05 versus normal control group and b P < 0.05 versus TAA control group. SY stands for Silymarin (standard hepatoprotective drug).